Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Stefan Gravenstein

Geriatric Medicine Norfolk, VA Medical Doctor

NPI 1447224191 CMS profile 292595

825 Fairfax Ave, Ste 500, Norfolk, VA 23507

Open in the dashboard

General payments

$305,718

180 records reported · program years 2019–2025

Research payments

$119

Paid to them · 1 record reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Research they led as principal investigator

$33,652,629 paid to institutions, not to them · program years 2019–2025

Through program year 2025, Stefan Gravenstein of Norfolk, VA is reported in the CMS Open Payments database as having received $305,718 across 180 general payments and $119 in research payments paid to them. Separately, studies naming them as principal investigator received $33,652,629 in research payments, paid to institutions rather than to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.

General payments for this record sit in the 99th percentile of Geriatric Medicine profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

8 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $66,853 20
2024 General $30,626 14
2023 General $93,297 56
2022 General $27,878 44
2021 General $23,285 9
2020 General $38,389 16
2019 General $25,390 21
2019 Research $119 1

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Stefan Gravenstein
  • Geriatric Medicine median
  • Middle half of Geriatric Medicine
  • National median

In program year 2025, general payments to Stefan Gravenstein were reported at $66,853. Among 512 Geriatric Medicine profiles paid that year, the median was $120 and the middle half received between $37 and $350.

Show as a table
Year Stefan Gravenstein Geriatric Medicine median Middle half National median
2019 $25,390 $96 $28–$339 $163
2020 $38,389 $99 $28–$262 $114
2021 $23,285 $94 $27–$318 $132
2022 $27,878 $103 $34–$338 $149
2023 $93,297 $109 $39–$320 $160
2024 $30,626 $125 $36–$371 $164
2025 $66,853 $120 $37–$350 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Sanofi Pasteur Inc. $70,153 25 payments
  2. Janssen Research & Development, LLC $47,270 3 payments
  3. Moderna TX, Inc. $41,280 31 payments
  4. Janssen Global Services, LLC $25,527 7 payments
  5. Pfizer Inc. $25,505 10 payments
  6. GlaxoSmithKline, LLC. $15,541 25 payments
  7. Novavax Inc $13,512 13 payments
  8. Janssen Scientific Affairs, LLC $13,421 7 payments
  9. F. Hoffmann-La Roche AG $12,222 6 payments
  10. AstraZeneca Pharmaceuticals LP $8,379 8 payments
  11. Other $32,909 45 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Consulting Fee $157,637 43 payments
  2. Travel and Lodging $68,678 68 payments
  3. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $64,892 16 payments
  4. Grant $5,000 1 payment
  5. Honoraria $4,900 1 payment
  6. Food and Beverage $4,561 50 payments
  7. Education $50 1 payment
Products named General payments · program years 2019–2025
  1. Moderna Covid-19 Vaccine $23,132 24 payments
  2. NOVAVAX COVID-19 VACCINE, ADJUVANTED $13,512 13 payments
  3. COMIRNATY $11,878 3 payments
  4. Xofluza Virology & Specialty Care $11,178 6 payments
  5. FLUZONE QUADRIVALENT NORTHERN HEMISPHERE $9,506 4 payments
  6. FLUZONE QUADRIVALENT $7,866 2 payments
  7. Xofluza Virology & Specialty Care $5,174 9 payments
  8. S-217622 $4,410 2 payments
  9. ZOSTAVAX $1,700 2 payments
  10. PAXLOVID $1,400 1 payment
  11. Other $1,043 7 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Research payments came from Research payments · program years 2019–2025
  1. Sanofi Pasteur Inc. $119 1 payment

Records

181 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record